+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Akebia Therapeutics Inc (AKBA) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

Akebia Therapeutics Inc (Akebia Therapeutics) is a developer of biopharmaceutical therapeutics based on hypoxia inducible factor for patients with kidney disease. The company offer products such as vadadustat for the treatment of anemia associated with chronic kidney disease and is in phase III clinical studies. It offers AKB-6899, second hypoxia provides factor-prolyl hydroxylase product candidate, that increases erythropoietin levels while reducing vascular endothelial growth factor levels with a capable use for the treatment of oncology and ophthalmology. The company operates in the US and Ireland. Akebia Therapeutics is headquartered in Cambridge, Massachusetts, the US.

Akebia Therapeutics Inc Key Recent Developments

Nov 08, 2017: Akebia Therapeutics Announces Third Quarter 2017 Financial Results
Aug 08, 2017: Akebia Announces Second Quarter 2017 Financial Results
May 25, 2017: Akebia Therapeutics Names Rita Jain, M.D. as Chief Medical Officer
May 09, 2017: Akebia Announces First Quarter 2017 Financial Results
Mar 06, 2017: Akebia Announces Fourth Quarter and Full-Year 2016 Financial Results

This comprehensive SWOT profile of Akebia Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Akebia Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • Akebia Therapeutics Inc - Key Information
  • Akebia Therapeutics Inc - Overview
  • Akebia Therapeutics Inc - Key Employees
  • Akebia Therapeutics Inc - Key Employee Biographies
  • Akebia Therapeutics Inc - Key Operational Heads
  • Akebia Therapeutics Inc - Major Products and Services
  • Akebia Therapeutics Inc - History
  • Akebia Therapeutics Inc - Company Statement
  • Akebia Therapeutics Inc - Locations And Subsidiaries
  • Akebia Therapeutics Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Akebia Therapeutics Inc - Business Description
  • Akebia Therapeutics Inc - Corporate Strategy
  • Akebia Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Akebia Therapeutics Inc - Strengths
  • Akebia Therapeutics Inc - Weaknesses
  • Akebia Therapeutics Inc - Opportunities
  • Akebia Therapeutics Inc - Threats
  • Akebia Therapeutics Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Akebia Therapeutics Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Akebia Therapeutics Inc, Key Information
  • Akebia Therapeutics Inc, Key Ratios
  • Akebia Therapeutics Inc, Share Data
  • Akebia Therapeutics Inc, Major Products and Services
  • Akebia Therapeutics Inc, History
  • Akebia Therapeutics Inc, Key Employees
  • Akebia Therapeutics Inc, Key Employee Biographies
  • Akebia Therapeutics Inc, Key Operational Heads
  • Akebia Therapeutics Inc, Other Locations
  • Akebia Therapeutics Inc, Subsidiaries
  • Akebia Therapeutics Inc, Key Manufacturing facilities
  • Akebia Therapeutics Inc, Key Competitors
  • Akebia Therapeutics Inc, SWOT Analysis
  • Akebia Therapeutics Inc, Ratios based on current share price
  • Akebia Therapeutics Inc, Annual Ratios
  • Akebia Therapeutics Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Akebia Therapeutics Inc, Performance Chart
  • Akebia Therapeutics Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3


Order Online - visit: https://www.researchandmarkets.com/reports/4285267